Insider · CIK 0002000308
Mark Torres
Files at CNVS (Cineverse Corp.). First filing Feb 17, 2026, latest Feb 17, 2026.
In brief
Mark Torres files SEC Form 4 as officer at CNVS (Cineverse Corp.). Since Feb 17, 2026, Mark Torres has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Mark Torres has 0, so none is measured yet.
The newest scored trade: bought $50k of CNVS on Feb 17, 2026, filed Feb 17, 2026, scored 48 (moderate). In the last 12 months: 1 buy worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CNVS: Cineverse Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Cineverse Corp. | $50k 25,000 shares | +16% | +48% from low-62% from high |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +25,607 | - | - | 205,165 | May 5, 2026 |
| May 1, 2026 | CNVS Cineverse Corp. | FTax withholding Class A Common Stock | -13,941 | $2.62 | $37k | 191,224 | May 5, 2026 |
| May 1, 2026 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -25,607 | $0.00 | $0 | 51,213 | May 5, 2026 |
| Apr 25, 2026 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +33,333 | - | - | 216,607 | Apr 28, 2026 |
| Apr 25, 2026 | CNVS Cineverse Corp. | FTax withholding Class A Common Stock | -37,049 | $2.39 | $89k | 179,558 | Apr 28, 2026 |
| Apr 25, 2026 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -33,333 | $0.00 | $0 | 33,333 | Apr 28, 2026 |
| Feb 17, 2026 | CNVS Cineverse Corp. | POpen-market purchase Class A Common Stock | +25,000 | $2.00 | $50k | 183,274 | Feb 17, 2026 |
| Oct 8, 2025 | CNVS Cineverse Corp. | AGrant or award Restricted Stock Unitderivative | +66,763 | $0.00 | $0 | 66,763 | Oct 10, 2025 |
| May 1, 2025 | CNVS Cineverse Corp. | AGrant or award Restricted Stock Unitderivative | +76,820 | $0.00 | $0 | 76,820 | May 5, 2025 |
| Apr 25, 2025 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +33,333 | - | - | 195,232 | Apr 29, 2025 |
| Apr 25, 2025 | CNVS Cineverse Corp. | FTax withholding Class A Common Stock | -36,958 | $3.00 | $111k | 158,274 | Apr 29, 2025 |
| Apr 25, 2025 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -33,333 | $0.00 | $0 | 66,667 | Apr 29, 2025 |
| Apr 25, 2024 | CNVS Cineverse Corp. | AGrant or award Class A Common Stock | +100,000 | $0.00 | $0 | 161,899 | Apr 26, 2024 |
| Apr 25, 2024 | CNVS Cineverse Corp. | AGrant or award Restricted Stock Unitderivative | +100,000 | $0.00 | $0 | 100,000 | Apr 26, 2024 |
Questions about Mark Torres
Answered from the filings on this page, as of the latest one.
Is Mark Torres buying or selling?
In the last 12 months Mark Torres reported 1 open-market buy worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $50k of CNVS on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Torres's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Torres has 0.
Where does Mark Torres file Form 4?
Mark Torres has filed Form 4 at CNVS (Cineverse Corp.) as Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.